| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |